Johnson & Johnson(JNJ) Stock Price Today

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US Stock MarketDetailed Quotes

JNJ Johnson & Johnson

Watchlist

162.220
+1.200+0.75%

Trading Mar 26 10:40 ET

390.56BMarket Cap28.02P/E (TTM)

Intraday

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Johnson & Johnson Presents New Nipocalimab Data And Real-World Research At AAN 2025 Highlighting Phase 3 Results And Commitment To People Living With Generalized Myasthenia Gravis
Benzinga08:13 ET
Express News | New Nipocalimab Data and Real-World Research at Aan 2025 Highlight Positive Phase 3 Results and Commitment to People Living With Generalized Myasthenia Gravis (Gmg)
Reuters08:03 ET
Marty Makary and Jay Bhattacharya Clear Senate Hurdles to Lead FDA and NIH
Seeking Alpha06:56 ET
Hospital Stocks Are Ready to Rebound, Deutsche Bank Says
BNN Bloomberg13:51 ET
Express News | Johnson & Johnson Medtech Launches Dualto™ Energy System for Use Across Surgical Treatment Approaches
ReutersMar 25 08:02 ET
Proposed Medicaid Cuts Would Devastate Local Economies: Report -- Barrons.com
Barron'sMar 25 00:01 ET

Comments

Teddy123

2 hours ago

New nipocalimab data and real-world research at AAN 2025 highlight positive Phase 3 results and commitment to people living with generalized myasthenia gravis (gMG)

$Johnson & Johnson (JNJ.US)$
Breakthrough Phase 3 Results: New Drug Shows Promise for Myasthenia Gravis, Including Pregnant Patients

ひな☆彡 SOXL ♡

18 hours ago

J&J Update

$Johnson & Johnson (JNJ.US)$
with yesterday’s breakout, it tocuhed the day bolinger. I expect more drop. hopefully in next several trading days.

RIPPER: ABOUT TIME……We have a breakout from neckline. Plenty of time to still enter this one. First target is 159, second target is 152.

RIPPER

21 hours ago

ABOUT TIME……We have a breakout from neckline. Plenty of time to still enter this one. First target is 159, second target is 152.

$Johnson & Johnson (JNJ.US)$

Teddy123

Mar 21 18:01

Johnson & Johnson Increases U.S. Investment to More than $55 Billion Over the Next Four Years

$Johnson & Johnson (JNJ.US)$
Johnson & Johnson's Massive $55B Investment: 4 New Plants, 500+ Jobs, and Game-Changing R&D Expansion

Teddy123

Mar 21 12:38

U.S. FDA approves TREMFYA® (guselkumab), the first and only IL-23 inhibitor offering both subcutaneous and intravenous induction options, for adult patients with moderately to severely active Crohn's

$Johnson & Johnson (JNJ.US)$
Breakthrough: TREMFYA Secures FDA Approval for Crohn's Disease Treatment with Industry-First Delivery Options

Market Insights

Symbol Mini Chart % Chg

Unlock the Full List